The device combines enhanced functionality with a patient-friendly design, simplifying the implant procedure and providing greater device longevity for patients with Central Sleep Apnea. According to Respicardia, features of the new device include: Extended longevity: 40% longer average battery life ...
Patients with obstructive or central sleep apnea are primarily treated with positive airway pressure treatment. There are novel implantable options targeti... A Steffen,C Schbel,J Vogler,... - 《Sleep & Breathing》 被引量: 0发表: 2024年 OBSTRUCTIVE SLEEP APNEA PATIENT PROGRAMMER FOR IMPLANTABLE ...
Long-Term Experience with First-Generation Implantable Neurostimulation Device in Central Sleep Apnea Treatmentdoi:10.1111/pace.13049Sleep-disordered breathing (SDB) and Cheyne-Stokes respiration (CSR) are associated with shorter survival in patients with heart failure. A novel treatment method for this ...
Zoll Medicalannouncedon April 12, 2021 that it had acquired Respicardia and its neurostimulation technology for treating sleep apnea. The financial terms of the deal were not disclosed. Respicardia makes implantable neurostimulators to treat moderate to severe central sleep apnea (CSA). The system ...
One aspect of the present subject matter relates to an implantable medical device. An embodiment of the device comprises a rechargeable power supply adapted to be recharged through
The device remained implanted for 12 months. At the end of 12 months, patients were given the option of device removal or continued monitoring as long as the device remained active. For some of the study patients, there was limited availability of the external loop recorders and lack of ...
An implantable wireless lead includes an enclosure, the enclosure housing: one or more electrodes configured to apply one or more electrical pulses to a neural tissue; a first anten
Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given hi...
[91]. Several solutions have been implemented to cope with the poor myoelectric signals provided by surface electrodes; for instance, in order to control two different devices (e.g. hand and wrist), the fast contraction of all the muscles involved is used to switch from one device to the ...
Bob Kronemyer (Contributor)